6 Ways We Prove Your Device Is Microbiologically Safe

Sterile isn’t a claim you get to make — it’s a claim you have to prove, checkpoint by checkpoint.

Microbiological and Sterility Testing sits underneath every medical device claim that touches a patient. Bacteria, fungi, spores, and endotoxin residues picked up during raw-material handling, moulding, assembly, or packaging don’t announce themselves — they have to be measured, controlled, and documented, checkpoint by checkpoint, before a regulator, a hospital procurement team, or a patient will trust the device. Our testing service at the Oragadam laboratory answers that requirement across six checkpoints that together cover the microbiological evidence file a notified body or CDSCO reviewer expects to see attached to your device master record, referenced to ISO 10993-7:2026 alongside ISO 11737-1 and ISO 11737-2 for bioburden and sterility test methods, and USP chapters <61>, <62>, <71>, and <85> for microbial limits, sterility, and endotoxin confirmation.

Microbial limits testing screens raw materials, components, and non-sterile finished devices for total aerobic microbial count, combined yeast and mould count, and the absence of specific pathogens — the first checkpoint before a device is even considered for further processing. The barrier evaluation checkpoint asks a different question: once a device is sterile, does the packaging system actually keep organisms out under real transport and storage stress, or only on the day it leaves the pouching line. This evaluation challenges a pouch, tray, or Tyvek lid with an aerosolised spore suspension to confirm the barrier holds after simulated distribution.

This checkpoint enumerates the total viable microbial load on a device prior to sterilization — the baseline figure every downstream sterilization dose-setting and cycle-validation study is built against. Get this number wrong and every subsequent study inherits the error. Sterility testing performed alongside sterilization validation confirms the finished, packaged device is genuinely free of viable organisms after your chosen cycle — steam, EO, gamma, or e-beam — using membrane filtration or direct inoculation per ISO 11737-2. Antimicrobial activity testing is reserved for devices carrying a claim, such as coated catheters, wound dressings, or impregnated sutures, and quantifies the zone of inhibition or log-reduction that claim depends on.

Endotoxin testing, run by the LAL kinetic-chromogenic method, catches what sterility testing cannot: pyrogenic residues from dead Gram-negative bacteria that survive sterilization intact and can still trigger a febrile reaction in a patient. This is why it runs as standard alongside implant and blood-contact device studies in our Medical Device Testing program at Oragadam — a device that passes sterility testing has not automatically passed the endotoxin question, and treating the two as interchangeable is a real gap in a regulatory submission. Manufacturers come to us because a single missed microbiological checkpoint can mean a recalled lot, a rejected submission, or a hospital tender lost to a competitor with a cleaner test file. Building bioburden, barrier, sterility, antimicrobial, and endotoxin checks into one accredited scope, with reports formatted for direct submission, turns six separate certificates into one coherent microbiological safety story your quality team can stand behind.

Kiyo R&D Lab – Oragadam

Our testing suite is based at No.13, Srinivasa Perumal Street, Panapakkam, Serapanacheri, Greater Chennai, Tamil Nadu 601301.

Book Your Microbiological and Sterility Testing Today

Talk to our Oragadam microbiology team about bioburden, barrier, sterility, or endotoxin studies for your Medical Device Testing programme.

Request Microbiological and Sterility Testing

Fill in your details below and our team will get back to you shortly.